EL SEGUNDO, Calif. — Gov. Gavin Newsom announced Thursday that CalRx biosimilar insulin glargine pens will be available to consumers in California beginning Jan. 1, 2026. The launch comes amid the ...

EXPECTING SOME FREEZING TEMPERATURES TO START ROLLING IN SCOTT. I FEEL LIKE THIS HAS TO BE THE BUZZ AT EVERY BREAK ROOM AT WORK THIS WEEK. HAVE YOU HEARD ABOUT THE COLD WEATHER THAT’S COMING? LOOK AT ...

Please provide your email address to receive an email when new articles are posted on . Adults with type 1 diabetes had a higher time in range if they usually administered bolus insulin after a missed ...

Pharmacy chain CVS will pay $37.8 million for dispensing and billing health care plans including the military’s Tricare for more insulin than was prescribed for the pharmacy’s diabetic customers, ...

The settlement resolves allegations that, from 2010 through 2020, CVS violated the False Claims Act in connection with its billing and dispensing of insulin pens to patients enrolled in government ...

CVS reached a settlement on Tuesday with the U.S. Attorney for the Southern District of New York for over $37.75 million after the retailer was accused of over-dispensing insulin pens to patients.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min According to the DOJ, CVS ...

CVS has agreed to pay almost $38 million to settle allegations that its pharmacies overcharged the government for insulin pens over a decade, putting to bed a Department of Justice lawsuit and several ...

CVS Health (CVS) has reached a settlement with the U.S. government, requiring the company to pay $37.76M to resolve claims that it overbilled government healthcare programs for insulin pens. The ...

NEW YORK, Dec 2 (Reuters) - CVS Health (CVS.N), opens new tab will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained improper reimbursements ...

NEW YORK, Dec 2 (Reuters) - CVS Health will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients and then sought reimbursement from government healthcare programs, U ...

CVS Health agreed to pay $37.76 million to settle allegations that it dispensed too many insulin pens to patients and improperly billed federal healthcare programs for those insulin prescriptions. The ...